Review



fluorescein conjugated horse anti mouse antibody  (Vector Laboratories)


Bioz Verified Symbol Vector Laboratories is a verified supplier
Bioz Manufacturer Symbol Vector Laboratories manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 94

    Structured Review

    Vector Laboratories fluorescein conjugated horse anti mouse antibody
    Fluorescein Conjugated Horse Anti Mouse Antibody, supplied by Vector Laboratories, used in various techniques. Bioz Stars score: 94/100, based on 150 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/fluorescein+conjugated+horse+anti+mouse/DyLight+488+Horse+Anti-Mouse+IgG+Antibody/10__3390_slash_j7030023-88-26-31
    Average 94 stars, based on 150 article reviews
    fluorescein conjugated horse anti mouse antibody - by Bioz Stars, 2026-09
    94/100 stars

    Images

    Related Articles

    Incubation:

    Article Title: Beneficial effects of Jiawei Shenqi-wan and treadmill training on deficits associated with neonatal hypoxic-ischemia in rats
    Article Snippet: The sections were incubated with primary antibodies against the following: BrdU (1:500; MCA2483; Bio-Rad Laboratories, Inc., Hercules, CA, USA), NeuN (1:500; ABN78; EMD Millipore), GFAP (1:500; AB5804; EMD Millipore), DCX (1:200; sc-8066; Santa Cruz Biotechnology, Inc.), and MBP (1:500; ab40390; Abcam) overnight in PBS at 4°C. .. Sections were washed three times with PBS for 10 min and subsequently incubated with the fluorescein-conjugated horse anti-mouse (1:200; FI-2000; Vector Laboratories, Inc.) and Texas Red-conjugated goat anti-rabbit (1:200; TI-1000; Vector Laboratories, Inc.) secondary antibodies for 2 h at room temperature in the dark and washed three times with PBS. .. Slides were mounted in mounting medium (Dako; Agilent Technologies, Inc., Santa Clara, CA, USA) and images were captured using a fluorescence microscope (Carl Zeiss Imager M1; Carl Zeiss AG, Oberkochen, Germany).

    Immunofluorescence:

    Article Title: Cell tracking, survival, and differentiation capacity of adipose-derived stem cells after engraftment in rat tissue.
    Article Snippet: CELL TRACKING, SURVIVAL AND DIFFERENTIATION CAPACITY OF ADIPOSEDERIVED STEM CELLS AFTER ENGRAFTMENT IN RAT TISSUE† Mario F. Muñoz1, Sandro Argüelles2, Matias Guzman-Chozas3, Remedios GuillénSanz3, Jaime M. Franco4, José A. Pintor-Toro4, Mercedes Cano2, Antonio Ayala1** 1Departamento de Bioquímicay Biología Molecular.. Universidad de Sevilla. (Spain) 2 Departamento de Fisiología y Zoología.. Universidad de Sevilla. (Spain) 3Departamento de Nutrición, Bromatología, Toxicología y Medicina Legal.



    Similar Products

    94
    Vector Laboratories fluorescein conjugated horse anti mouse antibody
    Fluorescein Conjugated Horse Anti Mouse Antibody, supplied by Vector Laboratories, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/fluorescein+conjugated+horse+anti+mouse/DyLight+488+Horse+Anti-Mouse+IgG+Antibody/10__3390_slash_j7030023-88-26-31
    Average 94 stars, based on 1 article reviews
    fluorescein conjugated horse anti mouse antibody - by Bioz Stars, 2026-09
    94/100 stars
      Buy from Supplier

    94
    Vector Laboratories anti mouse fluorescein isothiocyanate fitc
    Development of antibodies to detect captured GPA33 in an ELISA format. Evaluation of RSE-05 in capture-sensor ELISA format using three distinct polyclonal antibodies to GPA33. A The indicated sera (from peptide 1 and peptide 2 derived from potential GPA33 surface loops; Supplementary Fig. 6) were validated for presence of peptide specific IgG; the sera was affinity purified on a peptide 1 or peptide 2 column, respectively, and after elution with 0.1 M glycine buffer (pH 2.5), fractions were reduced and separated on an SDS gel and stained with Coomassie Blue to validate the presence and amounts of peptide-specific IgG. B Dot-blotting of transfected HEK293T cell lysates without or with GPA33. 7.5 μg of protein lysate was used in each dot. Left, empty-vector transfections. Right, GPA33-gene transfections. Polyclonal fractions 1.5 and 2.6 were used for peptide 1 and peptide 2 respectively. C Anti-GPA33 activity of polyclonal sera by ELISA format, fractions 1.5 and 2.6. 200 ng of tagged GPA33 was coated, or with pre-treatment using 50 mM DTT to reduce di-sulphide bonds, with uncoated wells as negative control. D Sandwich ELISAs using three different polyclonal antibodies in conjunction with RSE-05 to determine whether RSE-05 can function in a capture-sensor format. The indicated antibodies were coated to the immunoplate wells as capture agents (RSE-05, Atlas polyclonal antibody, CPF1.5 P1 polyclonal antibody or CEG 2.6 P2 polyclonal antibody). Following this, 200 ng of recombinant GPA33 protein (FC tagged) was added then complementary antibodies were added in sensor format, labelled as <t>‘detection’.</t> <t>Anti-mouse</t> or anti-rabbit HRP secondary antibodies were then added, and signal measured using HRP and luminescence
    Anti Mouse Fluorescein Isothiocyanate Fitc, supplied by Vector Laboratories, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/fluorescein+conjugated+horse+anti+mouse/Fluorescein+Horse+Anti-Mouse+IgG+Antibody/pmc13088578-186-5-11
    Average 94 stars, based on 1 article reviews
    anti mouse fluorescein isothiocyanate fitc - by Bioz Stars, 2026-09
    94/100 stars
      Buy from Supplier

    94
    Vector Laboratories fitc
    Development of antibodies to detect captured GPA33 in an ELISA format. Evaluation of RSE-05 in capture-sensor ELISA format using three distinct polyclonal antibodies to GPA33. A The indicated sera (from peptide 1 and peptide 2 derived from potential GPA33 surface loops; Supplementary Fig. 6) were validated for presence of peptide specific IgG; the sera was affinity purified on a peptide 1 or peptide 2 column, respectively, and after elution with 0.1 M glycine buffer (pH 2.5), fractions were reduced and separated on an SDS gel and stained with Coomassie Blue to validate the presence and amounts of peptide-specific IgG. B Dot-blotting of transfected HEK293T cell lysates without or with GPA33. 7.5 μg of protein lysate was used in each dot. Left, empty-vector transfections. Right, GPA33-gene transfections. Polyclonal fractions 1.5 and 2.6 were used for peptide 1 and peptide 2 respectively. C Anti-GPA33 activity of polyclonal sera by ELISA format, fractions 1.5 and 2.6. 200 ng of tagged GPA33 was coated, or with pre-treatment using 50 mM DTT to reduce di-sulphide bonds, with uncoated wells as negative control. D Sandwich ELISAs using three different polyclonal antibodies in conjunction with RSE-05 to determine whether RSE-05 can function in a capture-sensor format. The indicated antibodies were coated to the immunoplate wells as capture agents (RSE-05, Atlas polyclonal antibody, CPF1.5 P1 polyclonal antibody or CEG 2.6 P2 polyclonal antibody). Following this, 200 ng of recombinant GPA33 protein (FC tagged) was added then complementary antibodies were added in sensor format, labelled as <t>‘detection’.</t> <t>Anti-mouse</t> or anti-rabbit HRP secondary antibodies were then added, and signal measured using HRP and luminescence
    Fitc, supplied by Vector Laboratories, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/fluorescein+conjugated+horse+anti+mouse/Fluorescein+Horse+Anti-Mouse+IgG+Antibody/pmc12913188-62-12-13
    Average 94 stars, based on 1 article reviews
    fitc - by Bioz Stars, 2026-09
    94/100 stars
      Buy from Supplier

    94
    Vector Laboratories fitc conjugated horse antimouse igg vector laboratories fi
    Development of antibodies to detect captured GPA33 in an ELISA format. Evaluation of RSE-05 in capture-sensor ELISA format using three distinct polyclonal antibodies to GPA33. A The indicated sera (from peptide 1 and peptide 2 derived from potential GPA33 surface loops; Supplementary Fig. 6) were validated for presence of peptide specific IgG; the sera was affinity purified on a peptide 1 or peptide 2 column, respectively, and after elution with 0.1 M glycine buffer (pH 2.5), fractions were reduced and separated on an SDS gel and stained with Coomassie Blue to validate the presence and amounts of peptide-specific IgG. B Dot-blotting of transfected HEK293T cell lysates without or with GPA33. 7.5 μg of protein lysate was used in each dot. Left, empty-vector transfections. Right, GPA33-gene transfections. Polyclonal fractions 1.5 and 2.6 were used for peptide 1 and peptide 2 respectively. C Anti-GPA33 activity of polyclonal sera by ELISA format, fractions 1.5 and 2.6. 200 ng of tagged GPA33 was coated, or with pre-treatment using 50 mM DTT to reduce di-sulphide bonds, with uncoated wells as negative control. D Sandwich ELISAs using three different polyclonal antibodies in conjunction with RSE-05 to determine whether RSE-05 can function in a capture-sensor format. The indicated antibodies were coated to the immunoplate wells as capture agents (RSE-05, Atlas polyclonal antibody, CPF1.5 P1 polyclonal antibody or CEG 2.6 P2 polyclonal antibody). Following this, 200 ng of recombinant GPA33 protein (FC tagged) was added then complementary antibodies were added in sensor format, labelled as <t>‘detection’.</t> <t>Anti-mouse</t> or anti-rabbit HRP secondary antibodies were then added, and signal measured using HRP and luminescence
    Fitc Conjugated Horse Antimouse Igg Vector Laboratories Fi, supplied by Vector Laboratories, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/fluorescein+conjugated+horse+anti+mouse/Fluorescein+Horse+Anti-Mouse+IgG+Antibody/pmc12463118__ADVS-12-e14194-s002-89-127-131
    Average 94 stars, based on 1 article reviews
    fitc conjugated horse antimouse igg vector laboratories fi - by Bioz Stars, 2026-09
    94/100 stars
      Buy from Supplier

    94
    Vector Laboratories fitc conjugated horse anti mouse igg secondary antibody
    Development of antibodies to detect captured GPA33 in an ELISA format. Evaluation of RSE-05 in capture-sensor ELISA format using three distinct polyclonal antibodies to GPA33. A The indicated sera (from peptide 1 and peptide 2 derived from potential GPA33 surface loops; Supplementary Fig. 6) were validated for presence of peptide specific IgG; the sera was affinity purified on a peptide 1 or peptide 2 column, respectively, and after elution with 0.1 M glycine buffer (pH 2.5), fractions were reduced and separated on an SDS gel and stained with Coomassie Blue to validate the presence and amounts of peptide-specific IgG. B Dot-blotting of transfected HEK293T cell lysates without or with GPA33. 7.5 μg of protein lysate was used in each dot. Left, empty-vector transfections. Right, GPA33-gene transfections. Polyclonal fractions 1.5 and 2.6 were used for peptide 1 and peptide 2 respectively. C Anti-GPA33 activity of polyclonal sera by ELISA format, fractions 1.5 and 2.6. 200 ng of tagged GPA33 was coated, or with pre-treatment using 50 mM DTT to reduce di-sulphide bonds, with uncoated wells as negative control. D Sandwich ELISAs using three different polyclonal antibodies in conjunction with RSE-05 to determine whether RSE-05 can function in a capture-sensor format. The indicated antibodies were coated to the immunoplate wells as capture agents (RSE-05, Atlas polyclonal antibody, CPF1.5 P1 polyclonal antibody or CEG 2.6 P2 polyclonal antibody). Following this, 200 ng of recombinant GPA33 protein (FC tagged) was added then complementary antibodies were added in sensor format, labelled as <t>‘detection’.</t> <t>Anti-mouse</t> or anti-rabbit HRP secondary antibodies were then added, and signal measured using HRP and luminescence
    Fitc Conjugated Horse Anti Mouse Igg Secondary Antibody, supplied by Vector Laboratories, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/fluorescein+conjugated+horse+anti+mouse/Fluorescein+Horse+Anti-Mouse+IgG+Antibody/pmc12142596__mmc1-53-14-20
    Average 94 stars, based on 1 article reviews
    fitc conjugated horse anti mouse igg secondary antibody - by Bioz Stars, 2026-09
    94/100 stars
      Buy from Supplier

    94
    Vector Laboratories anti mouse antibodies conjugated with fitch
    Development of antibodies to detect captured GPA33 in an ELISA format. Evaluation of RSE-05 in capture-sensor ELISA format using three distinct polyclonal antibodies to GPA33. A The indicated sera (from peptide 1 and peptide 2 derived from potential GPA33 surface loops; Supplementary Fig. 6) were validated for presence of peptide specific IgG; the sera was affinity purified on a peptide 1 or peptide 2 column, respectively, and after elution with 0.1 M glycine buffer (pH 2.5), fractions were reduced and separated on an SDS gel and stained with Coomassie Blue to validate the presence and amounts of peptide-specific IgG. B Dot-blotting of transfected HEK293T cell lysates without or with GPA33. 7.5 μg of protein lysate was used in each dot. Left, empty-vector transfections. Right, GPA33-gene transfections. Polyclonal fractions 1.5 and 2.6 were used for peptide 1 and peptide 2 respectively. C Anti-GPA33 activity of polyclonal sera by ELISA format, fractions 1.5 and 2.6. 200 ng of tagged GPA33 was coated, or with pre-treatment using 50 mM DTT to reduce di-sulphide bonds, with uncoated wells as negative control. D Sandwich ELISAs using three different polyclonal antibodies in conjunction with RSE-05 to determine whether RSE-05 can function in a capture-sensor format. The indicated antibodies were coated to the immunoplate wells as capture agents (RSE-05, Atlas polyclonal antibody, CPF1.5 P1 polyclonal antibody or CEG 2.6 P2 polyclonal antibody). Following this, 200 ng of recombinant GPA33 protein (FC tagged) was added then complementary antibodies were added in sensor format, labelled as <t>‘detection’.</t> <t>Anti-mouse</t> or anti-rabbit HRP secondary antibodies were then added, and signal measured using HRP and luminescence
    Anti Mouse Antibodies Conjugated With Fitch, supplied by Vector Laboratories, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/fluorescein+conjugated+horse+anti+mouse/Fluorescein+Horse+Anti-Mouse+IgG+Antibody/pm39657061-49-7-13
    Average 94 stars, based on 1 article reviews
    anti mouse antibodies conjugated with fitch - by Bioz Stars, 2026-09
    94/100 stars
      Buy from Supplier

    94
    Vector Laboratories fitc conjugated goat anti mouse igg1 secondary antibodies
    Efficiency of viral growth, entry, and expression of G protein of each recombinant viruses in Vero cells. ( a ) Information on recombinant viruses used in this figure. *: Amino acid sequence identical with rHEP. **: Amino acid positions are numbered based on the mature G protein without signal peptide. ( b ) Vero cells were inoculated with the indicated recombinant viruses ( a ) at a M.O.I. of 0.05 and supernatants were collected every day until 4 d.p.i. Viral titers were determined in MNA cells. ( c ) The total number of focuses was determined by counting the number of focuses stained with the <t>FITC</t> anti-rabies monoclonal globulin in Vero or MNA cells under a fluorescence microscope. The ratio of the number of focuses in Vero to that in MNA was compared. ( d ) The particle titer of each secreted alkaline phosphatase (SEAP)-expressing VSVp stock was determined in MNA cells. Vero cells then were inoculated with two-fold serial dilutions (starting from 150 particles) of VSVp pseudotyped with the HEP or HEP-10V G protein SEAP activity was assessed in culture supernatants and detected by optical density (OD). ( e ) Vero cells were inoculated with each recombinant virus at an M.O.I. of 5 and harvested at 2 d.p.i. The cells were stained with anti-rabies G protein monoclonal antibody (#7-1-9) and <t>FITC-conjugated</t> anti-mouse secondary. After that, cells were fixed with 4% paraformaldehyde, and finally analyzed by BD FACS Canto II flow cytometer (Becton Dickinson and Company; BD, Franklin Lakes, NJ, USA) and Kaluza analysis software Version 2.1 (Beckman Coulter Life Sciences, Indianapolis, IN, USA). Data are presented as the mean and S.D. from three ( b , d , e ) or four ( c ) independent experiments. Significant differences are indicated in the comparison between rHEP and each recombinant virus after application of two-way ANOVA followed by Tukey ( b ), or each virus after application of one-way ANOVA followed by Turkey ( c , e ) or two-way ANOVA followed by Sidaks ( d ) (*: p < 0.05, **: p < 0.01, ***: p < 0.001).
    Fitc Conjugated Goat Anti Mouse Igg1 Secondary Antibodies, supplied by Vector Laboratories, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/fluorescein+conjugated+horse+anti+mouse/Fluorescein+Horse+Anti-Mouse+IgG+Antibody/pmc11143356-327-14-22
    Average 94 stars, based on 1 article reviews
    fitc conjugated goat anti mouse igg1 secondary antibodies - by Bioz Stars, 2026-09
    94/100 stars
      Buy from Supplier

    94
    Vector Laboratories horse anti rabbit igg antibody h l conjugated with fitc
    Efficiency of viral growth, entry, and expression of G protein of each recombinant viruses in Vero cells. ( a ) Information on recombinant viruses used in this figure. *: Amino acid sequence identical with rHEP. **: Amino acid positions are numbered based on the mature G protein without signal peptide. ( b ) Vero cells were inoculated with the indicated recombinant viruses ( a ) at a M.O.I. of 0.05 and supernatants were collected every day until 4 d.p.i. Viral titers were determined in MNA cells. ( c ) The total number of focuses was determined by counting the number of focuses stained with the <t>FITC</t> anti-rabies monoclonal globulin in Vero or MNA cells under a fluorescence microscope. The ratio of the number of focuses in Vero to that in MNA was compared. ( d ) The particle titer of each secreted alkaline phosphatase (SEAP)-expressing VSVp stock was determined in MNA cells. Vero cells then were inoculated with two-fold serial dilutions (starting from 150 particles) of VSVp pseudotyped with the HEP or HEP-10V G protein SEAP activity was assessed in culture supernatants and detected by optical density (OD). ( e ) Vero cells were inoculated with each recombinant virus at an M.O.I. of 5 and harvested at 2 d.p.i. The cells were stained with anti-rabies G protein monoclonal antibody (#7-1-9) and <t>FITC-conjugated</t> anti-mouse secondary. After that, cells were fixed with 4% paraformaldehyde, and finally analyzed by BD FACS Canto II flow cytometer (Becton Dickinson and Company; BD, Franklin Lakes, NJ, USA) and Kaluza analysis software Version 2.1 (Beckman Coulter Life Sciences, Indianapolis, IN, USA). Data are presented as the mean and S.D. from three ( b , d , e ) or four ( c ) independent experiments. Significant differences are indicated in the comparison between rHEP and each recombinant virus after application of two-way ANOVA followed by Tukey ( b ), or each virus after application of one-way ANOVA followed by Turkey ( c , e ) or two-way ANOVA followed by Sidaks ( d ) (*: p < 0.05, **: p < 0.01, ***: p < 0.001).
    Horse Anti Rabbit Igg Antibody H L Conjugated With Fitc, supplied by Vector Laboratories, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/fluorescein+conjugated+horse+anti+mouse/Fluorescein+Horse+Anti-Mouse+IgG+Antibody/pmc10020924-116-34-42
    Average 94 stars, based on 1 article reviews
    horse anti rabbit igg antibody h l conjugated with fitc - by Bioz Stars, 2026-09
    94/100 stars
      Buy from Supplier

    86
    Thermo Fisher antibody fluorescein red conjugated horse anti mouse igg
    Efficiency of viral growth, entry, and expression of G protein of each recombinant viruses in Vero cells. ( a ) Information on recombinant viruses used in this figure. *: Amino acid sequence identical with rHEP. **: Amino acid positions are numbered based on the mature G protein without signal peptide. ( b ) Vero cells were inoculated with the indicated recombinant viruses ( a ) at a M.O.I. of 0.05 and supernatants were collected every day until 4 d.p.i. Viral titers were determined in MNA cells. ( c ) The total number of focuses was determined by counting the number of focuses stained with the <t>FITC</t> anti-rabies monoclonal globulin in Vero or MNA cells under a fluorescence microscope. The ratio of the number of focuses in Vero to that in MNA was compared. ( d ) The particle titer of each secreted alkaline phosphatase (SEAP)-expressing VSVp stock was determined in MNA cells. Vero cells then were inoculated with two-fold serial dilutions (starting from 150 particles) of VSVp pseudotyped with the HEP or HEP-10V G protein SEAP activity was assessed in culture supernatants and detected by optical density (OD). ( e ) Vero cells were inoculated with each recombinant virus at an M.O.I. of 5 and harvested at 2 d.p.i. The cells were stained with anti-rabies G protein monoclonal antibody (#7-1-9) and <t>FITC-conjugated</t> anti-mouse secondary. After that, cells were fixed with 4% paraformaldehyde, and finally analyzed by BD FACS Canto II flow cytometer (Becton Dickinson and Company; BD, Franklin Lakes, NJ, USA) and Kaluza analysis software Version 2.1 (Beckman Coulter Life Sciences, Indianapolis, IN, USA). Data are presented as the mean and S.D. from three ( b , d , e ) or four ( c ) independent experiments. Significant differences are indicated in the comparison between rHEP and each recombinant virus after application of two-way ANOVA followed by Tukey ( b ), or each virus after application of one-way ANOVA followed by Turkey ( c , e ) or two-way ANOVA followed by Sidaks ( d ) (*: p < 0.05, **: p < 0.01, ***: p < 0.001).
    Antibody Fluorescein Red Conjugated Horse Anti Mouse Igg, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/fluorescein+conjugated+horse+anti+mouse/pmc03189611-87-60-69
    Average 86 stars, based on 1 article reviews
    antibody fluorescein red conjugated horse anti mouse igg - by Bioz Stars, 2026-09
    86/100 stars
      Buy from Supplier

    95
    Vector Laboratories horse anti mouse conjugated to fluorescein isothiocyanate fitc
    Efficiency of viral growth, entry, and expression of G protein of each recombinant viruses in Vero cells. ( a ) Information on recombinant viruses used in this figure. *: Amino acid sequence identical with rHEP. **: Amino acid positions are numbered based on the mature G protein without signal peptide. ( b ) Vero cells were inoculated with the indicated recombinant viruses ( a ) at a M.O.I. of 0.05 and supernatants were collected every day until 4 d.p.i. Viral titers were determined in MNA cells. ( c ) The total number of focuses was determined by counting the number of focuses stained with the <t>FITC</t> anti-rabies monoclonal globulin in Vero or MNA cells under a fluorescence microscope. The ratio of the number of focuses in Vero to that in MNA was compared. ( d ) The particle titer of each secreted alkaline phosphatase (SEAP)-expressing VSVp stock was determined in MNA cells. Vero cells then were inoculated with two-fold serial dilutions (starting from 150 particles) of VSVp pseudotyped with the HEP or HEP-10V G protein SEAP activity was assessed in culture supernatants and detected by optical density (OD). ( e ) Vero cells were inoculated with each recombinant virus at an M.O.I. of 5 and harvested at 2 d.p.i. The cells were stained with anti-rabies G protein monoclonal antibody (#7-1-9) and <t>FITC-conjugated</t> anti-mouse secondary. After that, cells were fixed with 4% paraformaldehyde, and finally analyzed by BD FACS Canto II flow cytometer (Becton Dickinson and Company; BD, Franklin Lakes, NJ, USA) and Kaluza analysis software Version 2.1 (Beckman Coulter Life Sciences, Indianapolis, IN, USA). Data are presented as the mean and S.D. from three ( b , d , e ) or four ( c ) independent experiments. Significant differences are indicated in the comparison between rHEP and each recombinant virus after application of two-way ANOVA followed by Tukey ( b ), or each virus after application of one-way ANOVA followed by Turkey ( c , e ) or two-way ANOVA followed by Sidaks ( d ) (*: p < 0.05, **: p < 0.01, ***: p < 0.001).
    Horse Anti Mouse Conjugated To Fluorescein Isothiocyanate Fitc, supplied by Vector Laboratories, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/fluorescein+conjugated+horse+anti+mouse/Unconjugated+Horse+Anti-Mouse+IgG+Antibody/pmc04745346-52-11-22
    Average 95 stars, based on 1 article reviews
    horse anti mouse conjugated to fluorescein isothiocyanate fitc - by Bioz Stars, 2026-09
    95/100 stars
      Buy from Supplier

    Image Search Results


    Development of antibodies to detect captured GPA33 in an ELISA format. Evaluation of RSE-05 in capture-sensor ELISA format using three distinct polyclonal antibodies to GPA33. A The indicated sera (from peptide 1 and peptide 2 derived from potential GPA33 surface loops; Supplementary Fig. 6) were validated for presence of peptide specific IgG; the sera was affinity purified on a peptide 1 or peptide 2 column, respectively, and after elution with 0.1 M glycine buffer (pH 2.5), fractions were reduced and separated on an SDS gel and stained with Coomassie Blue to validate the presence and amounts of peptide-specific IgG. B Dot-blotting of transfected HEK293T cell lysates without or with GPA33. 7.5 μg of protein lysate was used in each dot. Left, empty-vector transfections. Right, GPA33-gene transfections. Polyclonal fractions 1.5 and 2.6 were used for peptide 1 and peptide 2 respectively. C Anti-GPA33 activity of polyclonal sera by ELISA format, fractions 1.5 and 2.6. 200 ng of tagged GPA33 was coated, or with pre-treatment using 50 mM DTT to reduce di-sulphide bonds, with uncoated wells as negative control. D Sandwich ELISAs using three different polyclonal antibodies in conjunction with RSE-05 to determine whether RSE-05 can function in a capture-sensor format. The indicated antibodies were coated to the immunoplate wells as capture agents (RSE-05, Atlas polyclonal antibody, CPF1.5 P1 polyclonal antibody or CEG 2.6 P2 polyclonal antibody). Following this, 200 ng of recombinant GPA33 protein (FC tagged) was added then complementary antibodies were added in sensor format, labelled as ‘detection’. Anti-mouse or anti-rabbit HRP secondary antibodies were then added, and signal measured using HRP and luminescence

    Journal: Cellular & Molecular Biology Letters

    Article Title: GPA33 forms a distinct diagnostic target class to Claudin 18.2 in oesophageal adenocarcinoma enabling the development of a novel GPA33 antibody-based detection platform

    doi: 10.1186/s11658-025-00852-1

    Figure Lengend Snippet: Development of antibodies to detect captured GPA33 in an ELISA format. Evaluation of RSE-05 in capture-sensor ELISA format using three distinct polyclonal antibodies to GPA33. A The indicated sera (from peptide 1 and peptide 2 derived from potential GPA33 surface loops; Supplementary Fig. 6) were validated for presence of peptide specific IgG; the sera was affinity purified on a peptide 1 or peptide 2 column, respectively, and after elution with 0.1 M glycine buffer (pH 2.5), fractions were reduced and separated on an SDS gel and stained with Coomassie Blue to validate the presence and amounts of peptide-specific IgG. B Dot-blotting of transfected HEK293T cell lysates without or with GPA33. 7.5 μg of protein lysate was used in each dot. Left, empty-vector transfections. Right, GPA33-gene transfections. Polyclonal fractions 1.5 and 2.6 were used for peptide 1 and peptide 2 respectively. C Anti-GPA33 activity of polyclonal sera by ELISA format, fractions 1.5 and 2.6. 200 ng of tagged GPA33 was coated, or with pre-treatment using 50 mM DTT to reduce di-sulphide bonds, with uncoated wells as negative control. D Sandwich ELISAs using three different polyclonal antibodies in conjunction with RSE-05 to determine whether RSE-05 can function in a capture-sensor format. The indicated antibodies were coated to the immunoplate wells as capture agents (RSE-05, Atlas polyclonal antibody, CPF1.5 P1 polyclonal antibody or CEG 2.6 P2 polyclonal antibody). Following this, 200 ng of recombinant GPA33 protein (FC tagged) was added then complementary antibodies were added in sensor format, labelled as ‘detection’. Anti-mouse or anti-rabbit HRP secondary antibodies were then added, and signal measured using HRP and luminescence

    Article Snippet: Then, cells were incubated with anti-mouse fluorescein isothiocyanate (FITC)-conjugated secondary antibody (Vector Laboratories Inc., Burlingame, CA, USA, cat. no. FI-2000-1.5) in the blocking solution for 30 min in the dark and washed twice in PBS.

    Techniques: Enzyme-linked Immunosorbent Assay, Derivative Assay, Affinity Purification, SDS-Gel, Staining, Transfection, Plasmid Preparation, Activity Assay, Negative Control, Recombinant

    The RSE-05 MAB binds to full-length GPA33 protein after transfection into human cells. A Validation of GPA33 expression plasmids in human cells. MCF7 cells were transfected with either HA-tagged (T) (lanes 1 and 3) or non-tagged (nT) full length GPA33 containing the transmembrane domain (lanes 2 and 4) expression plasmids, and after acquiring the cell lysates using urea lysis buffer (8 M urea in PBS), a denaturing immunoblot was processed in lanes that either contain DTT (D) (lanes 1 and 2) or without DTT in the sample loading buffer (lanes 3–5). Lysates from non-transfected MCF7 cells are in lane 5. Samples were immunoblotted with the Atlas pAb (commercial antibody), which can detect all isoforms of GPA33. The presumed monomeric form of GPA33 has a faster mobility in the absence of DTT, which presumably reflects SDS resistance of the two IgG-like lobes to denaturation due to the three di-sulphide bonds. B Analysis of RSE-05 MAB binding to GPA33 in fixed cells using immunofluorescence. C , D Analysis of RSE-05 MAB binding to cell surface localized GPA33 in living cells. MCF7 cells were mock transfected ( C ) or transfected with the GPA33 expression plasmid ( D ) and processed by flow cytometry. The data are plotted as: left panels, FITC-A is plotted as a function of FSC-A; right panels, cell count is plotted as a function of FITC-A (left panels and right panels). E MCF7 cells were stably transfected with the GPA33 expression plasmid and flow cytometry was used to isolate the positive cells (in grey) separated from the GPA33 negative cells (in red). The data are plotted as: FITC-A as a function of FSC-A stable GPA33-positive cells and GPA33-negative negative cells. F Analysis of individual GPA33 + cell clones, 3, 7 and 11. Three GPA33 stably expressing cell clones were processed by flow cytometry to measure GPA33-positive staining with the RSE-05 MAB. The data are plotted as: GPA33-positive cells as a function of FITC-A

    Journal: Cellular & Molecular Biology Letters

    Article Title: GPA33 forms a distinct diagnostic target class to Claudin 18.2 in oesophageal adenocarcinoma enabling the development of a novel GPA33 antibody-based detection platform

    doi: 10.1186/s11658-025-00852-1

    Figure Lengend Snippet: The RSE-05 MAB binds to full-length GPA33 protein after transfection into human cells. A Validation of GPA33 expression plasmids in human cells. MCF7 cells were transfected with either HA-tagged (T) (lanes 1 and 3) or non-tagged (nT) full length GPA33 containing the transmembrane domain (lanes 2 and 4) expression plasmids, and after acquiring the cell lysates using urea lysis buffer (8 M urea in PBS), a denaturing immunoblot was processed in lanes that either contain DTT (D) (lanes 1 and 2) or without DTT in the sample loading buffer (lanes 3–5). Lysates from non-transfected MCF7 cells are in lane 5. Samples were immunoblotted with the Atlas pAb (commercial antibody), which can detect all isoforms of GPA33. The presumed monomeric form of GPA33 has a faster mobility in the absence of DTT, which presumably reflects SDS resistance of the two IgG-like lobes to denaturation due to the three di-sulphide bonds. B Analysis of RSE-05 MAB binding to GPA33 in fixed cells using immunofluorescence. C , D Analysis of RSE-05 MAB binding to cell surface localized GPA33 in living cells. MCF7 cells were mock transfected ( C ) or transfected with the GPA33 expression plasmid ( D ) and processed by flow cytometry. The data are plotted as: left panels, FITC-A is plotted as a function of FSC-A; right panels, cell count is plotted as a function of FITC-A (left panels and right panels). E MCF7 cells were stably transfected with the GPA33 expression plasmid and flow cytometry was used to isolate the positive cells (in grey) separated from the GPA33 negative cells (in red). The data are plotted as: FITC-A as a function of FSC-A stable GPA33-positive cells and GPA33-negative negative cells. F Analysis of individual GPA33 + cell clones, 3, 7 and 11. Three GPA33 stably expressing cell clones were processed by flow cytometry to measure GPA33-positive staining with the RSE-05 MAB. The data are plotted as: GPA33-positive cells as a function of FITC-A

    Article Snippet: Then, cells were incubated with anti-mouse fluorescein isothiocyanate (FITC)-conjugated secondary antibody (Vector Laboratories Inc., Burlingame, CA, USA, cat. no. FI-2000-1.5) in the blocking solution for 30 min in the dark and washed twice in PBS.

    Techniques: Transfection, Biomarker Discovery, Expressing, Lysis, Western Blot, Binding Assay, Immunofluorescence, Plasmid Preparation, Flow Cytometry, Cell Characterization, Stable Transfection, Clone Assay, Staining

    The epitope of the RSE-05 IgG is sensitive to reduction. A The indicated antibodies were used in immunoblots using purified His-tagged GPA33 protein without or with DTT in the SDS loading buffer. After incubating with the primary antibodies and adding anti-mouse or anti-rabbit HRP-conjugated secondary antibodies, membranes were stained using TMB. B ELISA was used to measure the binding activity of the RSE-05 MAB compared with the commercially available rabbit polyclonal antibody (Atlas pAb). Using GPA33 treated with the indicated chemicals (0.5% v/v SDS and/or 50 mM DTT), at different temperatures, RSE-05 and Atlas pAb (commercial antibody) binding was evaluated using anti-mouse or anti-rabbit HRP-conjugated secondary antibody, respectively. The binding activity is measured in luminescence, relative light units. C ELISA performed as in B , in this case with DTT titrated

    Journal: Cellular & Molecular Biology Letters

    Article Title: GPA33 forms a distinct diagnostic target class to Claudin 18.2 in oesophageal adenocarcinoma enabling the development of a novel GPA33 antibody-based detection platform

    doi: 10.1186/s11658-025-00852-1

    Figure Lengend Snippet: The epitope of the RSE-05 IgG is sensitive to reduction. A The indicated antibodies were used in immunoblots using purified His-tagged GPA33 protein without or with DTT in the SDS loading buffer. After incubating with the primary antibodies and adding anti-mouse or anti-rabbit HRP-conjugated secondary antibodies, membranes were stained using TMB. B ELISA was used to measure the binding activity of the RSE-05 MAB compared with the commercially available rabbit polyclonal antibody (Atlas pAb). Using GPA33 treated with the indicated chemicals (0.5% v/v SDS and/or 50 mM DTT), at different temperatures, RSE-05 and Atlas pAb (commercial antibody) binding was evaluated using anti-mouse or anti-rabbit HRP-conjugated secondary antibody, respectively. The binding activity is measured in luminescence, relative light units. C ELISA performed as in B , in this case with DTT titrated

    Article Snippet: Then, cells were incubated with anti-mouse fluorescein isothiocyanate (FITC)-conjugated secondary antibody (Vector Laboratories Inc., Burlingame, CA, USA, cat. no. FI-2000-1.5) in the blocking solution for 30 min in the dark and washed twice in PBS.

    Techniques: Western Blot, Purification, Staining, Enzyme-linked Immunosorbent Assay, Binding Assay, Activity Assay

    Efficiency of viral growth, entry, and expression of G protein of each recombinant viruses in Vero cells. ( a ) Information on recombinant viruses used in this figure. *: Amino acid sequence identical with rHEP. **: Amino acid positions are numbered based on the mature G protein without signal peptide. ( b ) Vero cells were inoculated with the indicated recombinant viruses ( a ) at a M.O.I. of 0.05 and supernatants were collected every day until 4 d.p.i. Viral titers were determined in MNA cells. ( c ) The total number of focuses was determined by counting the number of focuses stained with the FITC anti-rabies monoclonal globulin in Vero or MNA cells under a fluorescence microscope. The ratio of the number of focuses in Vero to that in MNA was compared. ( d ) The particle titer of each secreted alkaline phosphatase (SEAP)-expressing VSVp stock was determined in MNA cells. Vero cells then were inoculated with two-fold serial dilutions (starting from 150 particles) of VSVp pseudotyped with the HEP or HEP-10V G protein SEAP activity was assessed in culture supernatants and detected by optical density (OD). ( e ) Vero cells were inoculated with each recombinant virus at an M.O.I. of 5 and harvested at 2 d.p.i. The cells were stained with anti-rabies G protein monoclonal antibody (#7-1-9) and FITC-conjugated anti-mouse secondary. After that, cells were fixed with 4% paraformaldehyde, and finally analyzed by BD FACS Canto II flow cytometer (Becton Dickinson and Company; BD, Franklin Lakes, NJ, USA) and Kaluza analysis software Version 2.1 (Beckman Coulter Life Sciences, Indianapolis, IN, USA). Data are presented as the mean and S.D. from three ( b , d , e ) or four ( c ) independent experiments. Significant differences are indicated in the comparison between rHEP and each recombinant virus after application of two-way ANOVA followed by Tukey ( b ), or each virus after application of one-way ANOVA followed by Turkey ( c , e ) or two-way ANOVA followed by Sidaks ( d ) (*: p < 0.05, **: p < 0.01, ***: p < 0.001).

    Journal: Scientific Reports

    Article Title: Construction of Vero cell-adapted rabies vaccine strain by five amino acid substitutions in HEP-Flury strain

    doi: 10.1038/s41598-024-63337-9

    Figure Lengend Snippet: Efficiency of viral growth, entry, and expression of G protein of each recombinant viruses in Vero cells. ( a ) Information on recombinant viruses used in this figure. *: Amino acid sequence identical with rHEP. **: Amino acid positions are numbered based on the mature G protein without signal peptide. ( b ) Vero cells were inoculated with the indicated recombinant viruses ( a ) at a M.O.I. of 0.05 and supernatants were collected every day until 4 d.p.i. Viral titers were determined in MNA cells. ( c ) The total number of focuses was determined by counting the number of focuses stained with the FITC anti-rabies monoclonal globulin in Vero or MNA cells under a fluorescence microscope. The ratio of the number of focuses in Vero to that in MNA was compared. ( d ) The particle titer of each secreted alkaline phosphatase (SEAP)-expressing VSVp stock was determined in MNA cells. Vero cells then were inoculated with two-fold serial dilutions (starting from 150 particles) of VSVp pseudotyped with the HEP or HEP-10V G protein SEAP activity was assessed in culture supernatants and detected by optical density (OD). ( e ) Vero cells were inoculated with each recombinant virus at an M.O.I. of 5 and harvested at 2 d.p.i. The cells were stained with anti-rabies G protein monoclonal antibody (#7-1-9) and FITC-conjugated anti-mouse secondary. After that, cells were fixed with 4% paraformaldehyde, and finally analyzed by BD FACS Canto II flow cytometer (Becton Dickinson and Company; BD, Franklin Lakes, NJ, USA) and Kaluza analysis software Version 2.1 (Beckman Coulter Life Sciences, Indianapolis, IN, USA). Data are presented as the mean and S.D. from three ( b , d , e ) or four ( c ) independent experiments. Significant differences are indicated in the comparison between rHEP and each recombinant virus after application of two-way ANOVA followed by Tukey ( b ), or each virus after application of one-way ANOVA followed by Turkey ( c , e ) or two-way ANOVA followed by Sidaks ( d ) (*: p < 0.05, **: p < 0.01, ***: p < 0.001).

    Article Snippet: Cells were then washed twice and reacted for 1 h on ice with the FITC-conjugated Goat Anti-Mouse IgG1 secondary antibodies (1:1600) (FI-2000; Vector Laboratories, Newark, CA, USA).

    Techniques: Expressing, Recombinant, Sequencing, Staining, Fluorescence, Microscopy, Activity Assay, Virus, Flow Cytometry, Software, Comparison